| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Strabismus | 22 | 2024 | 65 | 2.660 |
Why?
|
| Photorefractive Keratectomy | 8 | 2021 | 65 | 2.430 |
Why?
|
| Anisometropia | 9 | 2012 | 19 | 1.950 |
Why?
|
| Amblyopia | 11 | 2019 | 34 | 1.940 |
Why?
|
| Oculomotor Muscles | 19 | 2024 | 80 | 1.890 |
Why?
|
| Myopia | 10 | 2023 | 120 | 1.840 |
Why?
|
| Retinopathy of Prematurity | 14 | 2016 | 64 | 1.650 |
Why?
|
| Ophthalmologic Surgical Procedures | 15 | 2024 | 95 | 1.490 |
Why?
|
| Visual Acuity | 23 | 2021 | 527 | 1.210 |
Why?
|
| Laser Coagulation | 9 | 2007 | 117 | 1.070 |
Why?
|
| Exotropia | 4 | 2021 | 21 | 1.000 |
Why?
|
| Cornea | 6 | 2021 | 561 | 0.820 |
Why?
|
| Lasers, Excimer | 8 | 2021 | 63 | 0.780 |
Why?
|
| Refraction, Ocular | 12 | 2023 | 184 | 0.710 |
Why?
|
| Duane Retraction Syndrome | 1 | 2021 | 1 | 0.690 |
Why?
|
| Refractive Surgical Procedures | 2 | 2012 | 40 | 0.670 |
Why?
|
| Corneal Topography | 3 | 2019 | 140 | 0.670 |
Why?
|
| Lens, Crystalline | 4 | 2008 | 104 | 0.660 |
Why?
|
| Child, Preschool | 49 | 2023 | 14994 | 0.650 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2021 | 43 | 0.650 |
Why?
|
| Eye Abnormalities | 5 | 2004 | 103 | 0.630 |
Why?
|
| Vision, Binocular | 9 | 2020 | 29 | 0.590 |
Why?
|
| Retinoblastoma | 5 | 2012 | 86 | 0.590 |
Why?
|
| Retinal Neoplasms | 5 | 2012 | 73 | 0.590 |
Why?
|
| Lens Implantation, Intraocular | 4 | 2017 | 186 | 0.560 |
Why?
|
| Nasolacrimal Duct | 3 | 2003 | 24 | 0.550 |
Why?
|
| Retinal Detachment | 6 | 2005 | 42 | 0.540 |
Why?
|
| Child | 53 | 2023 | 26182 | 0.510 |
Why?
|
| Refractive Errors | 4 | 2017 | 59 | 0.510 |
Why?
|
| Hemangioma, Capillary | 3 | 2007 | 20 | 0.500 |
Why?
|
| Retinal Diseases | 4 | 2004 | 151 | 0.490 |
Why?
|
| Suture Techniques | 5 | 2007 | 176 | 0.470 |
Why?
|
| Vision Disorders | 4 | 2019 | 195 | 0.470 |
Why?
|
| Vision Tests | 4 | 2023 | 24 | 0.450 |
Why?
|
| Orbital Neoplasms | 2 | 2007 | 49 | 0.450 |
Why?
|
| Needles | 2 | 2007 | 50 | 0.440 |
Why?
|
| Prospective Studies | 20 | 2021 | 6489 | 0.430 |
Why?
|
| Humans | 103 | 2024 | 130599 | 0.430 |
Why?
|
| Vision, Ocular | 2 | 2007 | 117 | 0.430 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1076 | 0.420 |
Why?
|
| Reflex, Pupillary | 3 | 2010 | 16 | 0.420 |
Why?
|
| Esotropia | 6 | 2009 | 19 | 0.400 |
Why?
|
| Sclera | 2 | 2007 | 45 | 0.390 |
Why?
|
| Hyperopia | 5 | 2009 | 59 | 0.380 |
Why?
|
| Infant | 32 | 2023 | 13302 | 0.380 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 6 | 2019 | 84 | 0.380 |
Why?
|
| Postoperative Complications | 4 | 2019 | 3111 | 0.370 |
Why?
|
| Corneal Surgery, Laser | 1 | 2012 | 11 | 0.370 |
Why?
|
| Male | 61 | 2021 | 64580 | 0.370 |
Why?
|
| Sensory Deprivation | 3 | 2007 | 10 | 0.340 |
Why?
|
| Cataract | 2 | 2002 | 151 | 0.340 |
Why?
|
| Vitreous Body | 4 | 2005 | 56 | 0.340 |
Why?
|
| Female | 63 | 2020 | 70540 | 0.330 |
Why?
|
| Depth Perception | 4 | 2004 | 16 | 0.320 |
Why?
|
| Eyelid Diseases | 2 | 2002 | 57 | 0.320 |
Why?
|
| Ophthalmology | 3 | 2019 | 180 | 0.320 |
Why?
|
| Retrospective Studies | 29 | 2024 | 17654 | 0.300 |
Why?
|
| Conjunctival Diseases | 2 | 2001 | 30 | 0.300 |
Why?
|
| Graves Disease | 2 | 2007 | 14 | 0.290 |
Why?
|
| Hemianopsia | 2 | 1999 | 25 | 0.280 |
Why?
|
| Cytomegalovirus Infections | 3 | 2019 | 219 | 0.280 |
Why?
|
| Gestational Age | 10 | 2019 | 1228 | 0.270 |
Why?
|
| Eye Movements | 6 | 2018 | 64 | 0.270 |
Why?
|
| Fovea Centralis | 1 | 2007 | 5 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 379 | 0.270 |
Why?
|
| Treatment Failure | 3 | 2012 | 350 | 0.270 |
Why?
|
| Retina | 3 | 2007 | 451 | 0.260 |
Why?
|
| Treatment Outcome | 17 | 2021 | 12901 | 0.260 |
Why?
|
| Glucocorticoids | 5 | 2003 | 341 | 0.260 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 97 | 0.260 |
Why?
|
| Sclerostomy | 1 | 2007 | 4 | 0.260 |
Why?
|
| Lasers, Semiconductor | 1 | 2007 | 8 | 0.260 |
Why?
|
| Thyrotropin | 1 | 2007 | 50 | 0.250 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 112 | 0.250 |
Why?
|
| Photography | 3 | 2004 | 80 | 0.250 |
Why?
|
| Graves Ophthalmopathy | 1 | 2007 | 17 | 0.250 |
Why?
|
| Interferon-alpha | 2 | 2007 | 240 | 0.250 |
Why?
|
| Dacryocystorhinostomy | 2 | 2003 | 22 | 0.250 |
Why?
|
| Immunoglobulins | 1 | 2007 | 156 | 0.240 |
Why?
|
| Anesthesia, General | 2 | 2004 | 138 | 0.230 |
Why?
|
| Optic Nerve | 3 | 2004 | 114 | 0.230 |
Why?
|
| Cyclophosphamide | 1 | 2007 | 436 | 0.230 |
Why?
|
| Infant, Newborn | 20 | 2017 | 8554 | 0.230 |
Why?
|
| Equipment Contamination | 2 | 2003 | 40 | 0.220 |
Why?
|
| Astigmatism | 2 | 2004 | 113 | 0.220 |
Why?
|
| Diplopia | 7 | 2019 | 43 | 0.220 |
Why?
|
| Epithelium, Corneal | 2 | 2004 | 174 | 0.220 |
Why?
|
| Keratitis, Herpetic | 1 | 2004 | 23 | 0.210 |
Why?
|
| Efficiency, Organizational | 1 | 2004 | 55 | 0.210 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 5226 | 0.210 |
Why?
|
| Panuveitis | 1 | 2003 | 3 | 0.200 |
Why?
|
| Chorioretinitis | 1 | 2003 | 3 | 0.200 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2003 | 3 | 0.200 |
Why?
|
| Munchausen Syndrome by Proxy | 1 | 2003 | 4 | 0.200 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 2003 | 5 | 0.200 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 89 | 0.200 |
Why?
|
| Conjunctivitis | 1 | 2003 | 21 | 0.200 |
Why?
|
| Betamethasone | 1 | 2003 | 10 | 0.200 |
Why?
|
| Intubation | 1 | 2003 | 16 | 0.200 |
Why?
|
| Silicone Elastomers | 1 | 2003 | 22 | 0.200 |
Why?
|
| Connective Tissue | 1 | 2003 | 26 | 0.200 |
Why?
|
| Treatment Refusal | 1 | 2004 | 79 | 0.200 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2003 | 20 | 0.200 |
Why?
|
| Association | 1 | 2003 | 4 | 0.200 |
Why?
|
| Foreign-Body Migration | 1 | 2003 | 58 | 0.190 |
Why?
|
| Glaucoma | 4 | 1999 | 87 | 0.190 |
Why?
|
| Choristoma | 1 | 2003 | 47 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 770 | 0.190 |
Why?
|
| Adolescent | 22 | 2019 | 20814 | 0.190 |
Why?
|
| Sutures | 1 | 2003 | 64 | 0.190 |
Why?
|
| Posture | 2 | 2004 | 120 | 0.180 |
Why?
|
| Lens Subluxation | 2 | 2017 | 4 | 0.180 |
Why?
|
| Endoscopy | 2 | 2003 | 272 | 0.180 |
Why?
|
| Head | 2 | 2004 | 112 | 0.180 |
Why?
|
| Mydriatics | 6 | 2004 | 14 | 0.170 |
Why?
|
| Radiation Injuries | 1 | 2002 | 145 | 0.170 |
Why?
|
| Orthoptera | 1 | 2001 | 2 | 0.170 |
Why?
|
| Facial Neoplasms | 2 | 1999 | 23 | 0.170 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2021 | 36 | 0.170 |
Why?
|
| Eye Infections, Viral | 2 | 2019 | 25 | 0.170 |
Why?
|
| Arthropod Venoms | 1 | 2001 | 7 | 0.170 |
Why?
|
| Time Factors | 6 | 2020 | 6237 | 0.170 |
Why?
|
| Patient Compliance | 4 | 2005 | 468 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2014 | 169 | 0.160 |
Why?
|
| Phakic Intraocular Lenses | 2 | 2012 | 3 | 0.160 |
Why?
|
| Cryotherapy | 2 | 1999 | 15 | 0.160 |
Why?
|
| Eye Diseases | 2 | 2000 | 108 | 0.160 |
Why?
|
| Insect Bites and Stings | 1 | 2001 | 39 | 0.160 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2000 | 16 | 0.160 |
Why?
|
| Atrophy | 1 | 2021 | 245 | 0.160 |
Why?
|
| Down Syndrome | 1 | 2003 | 235 | 0.160 |
Why?
|
| Anterior Chamber | 2 | 2008 | 27 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2001 | 247 | 0.160 |
Why?
|
| Nose Diseases | 1 | 2000 | 7 | 0.160 |
Why?
|
| Mucocele | 1 | 2000 | 6 | 0.160 |
Why?
|
| Drug Therapy, Combination | 6 | 2007 | 1164 | 0.160 |
Why?
|
| Corneal Diseases | 1 | 2001 | 94 | 0.150 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2000 | 41 | 0.150 |
Why?
|
| Models, Anatomic | 3 | 2010 | 106 | 0.150 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1999 | 16 | 0.150 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2000 | 35 | 0.150 |
Why?
|
| Saccades | 1 | 1999 | 20 | 0.150 |
Why?
|
| Bacteria | 2 | 2003 | 537 | 0.150 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 155 | 0.150 |
Why?
|
| Wound Healing | 1 | 2003 | 476 | 0.150 |
Why?
|
| Brain Diseases | 2 | 1998 | 302 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1999 | 133 | 0.140 |
Why?
|
| Spinal Dysraphism | 1 | 2002 | 288 | 0.140 |
Why?
|
| Pons | 1 | 1998 | 34 | 0.140 |
Why?
|
| Abducens Nerve Diseases | 1 | 1998 | 12 | 0.140 |
Why?
|
| Battered Child Syndrome | 1 | 1998 | 3 | 0.140 |
Why?
|
| Ecchymosis | 1 | 1998 | 12 | 0.140 |
Why?
|
| Play and Playthings | 1 | 1998 | 16 | 0.140 |
Why?
|
| Biometry | 3 | 2023 | 102 | 0.140 |
Why?
|
| Traction | 1 | 1997 | 10 | 0.140 |
Why?
|
| Cysts | 1 | 1998 | 89 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 258 | 0.140 |
Why?
|
| Neoplasms, Vascular Tissue | 1 | 1997 | 3 | 0.130 |
Why?
|
| Adult | 18 | 2024 | 31230 | 0.130 |
Why?
|
| Eye Enucleation | 4 | 2012 | 34 | 0.130 |
Why?
|
| Whooping Cough | 1 | 1998 | 60 | 0.130 |
Why?
|
| Visual Cortex | 1 | 2019 | 126 | 0.130 |
Why?
|
| Cavernous Sinus | 1 | 1997 | 24 | 0.130 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 8 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2021 | 393 | 0.130 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 1997 | 50 | 0.130 |
Why?
|
| Tubulin | 1 | 2017 | 75 | 0.130 |
Why?
|
| Parents | 1 | 2004 | 1108 | 0.130 |
Why?
|
| Conservative Treatment | 1 | 2017 | 43 | 0.130 |
Why?
|
| Ophthalmoscopy | 2 | 2010 | 32 | 0.130 |
Why?
|
| Choroid Hemorrhage | 1 | 1996 | 1 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2003 | 558 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2010 | 2126 | 0.120 |
Why?
|
| Data Collection | 1 | 1998 | 366 | 0.120 |
Why?
|
| Retinoscopy | 2 | 2007 | 8 | 0.120 |
Why?
|
| Term Birth | 1 | 2016 | 35 | 0.120 |
Why?
|
| Axial Length, Eye | 1 | 2016 | 37 | 0.120 |
Why?
|
| Rupture | 3 | 2000 | 34 | 0.120 |
Why?
|
| Cataract Extraction | 3 | 2002 | 129 | 0.120 |
Why?
|
| Eye | 3 | 2023 | 219 | 0.110 |
Why?
|
| Accommodation, Ocular | 2 | 2009 | 10 | 0.110 |
Why?
|
| Marfan Syndrome | 1 | 2017 | 146 | 0.110 |
Why?
|
| Recurrence | 6 | 2004 | 1477 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 1996 | 143 | 0.110 |
Why?
|
| Sympathomimetics | 1 | 2014 | 10 | 0.110 |
Why?
|
| Hemorrhage | 1 | 1998 | 498 | 0.110 |
Why?
|
| Skin | 1 | 1997 | 547 | 0.110 |
Why?
|
| Risk Factors | 9 | 2019 | 10991 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 2014 | 48 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 3 | 2017 | 30 | 0.110 |
Why?
|
| Caffeine | 1 | 2014 | 67 | 0.100 |
Why?
|
| Visual Fields | 3 | 2000 | 139 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 129 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2005 | 3417 | 0.100 |
Why?
|
| Dopamine | 1 | 2014 | 250 | 0.100 |
Why?
|
| Safety | 2 | 2004 | 214 | 0.090 |
Why?
|
| Diagnosis, Differential | 5 | 2003 | 1894 | 0.090 |
Why?
|
| Genes, Retinoblastoma | 1 | 2011 | 22 | 0.090 |
Why?
|
| Brain | 3 | 2003 | 3209 | 0.090 |
Why?
|
| Pediatrics | 1 | 2001 | 1241 | 0.090 |
Why?
|
| Young Adult | 3 | 2021 | 10011 | 0.090 |
Why?
|
| Decision Making | 1 | 2017 | 688 | 0.090 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 78 | 0.090 |
Why?
|
| Observer Variation | 2 | 2010 | 317 | 0.090 |
Why?
|
| Premature Birth | 1 | 2016 | 423 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2001 | 1215 | 0.090 |
Why?
|
| Eyeglasses | 2 | 2009 | 8 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2005 | 1462 | 0.080 |
Why?
|
| Ophthalmic Solutions | 3 | 2000 | 89 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 270 | 0.080 |
Why?
|
| Probability | 1 | 2010 | 306 | 0.080 |
Why?
|
| Biopsy | 2 | 2007 | 1241 | 0.080 |
Why?
|
| Hyphema | 2 | 2000 | 3 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 4927 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2004 | 329 | 0.080 |
Why?
|
| Fibrosis | 2 | 2002 | 419 | 0.080 |
Why?
|
| Antiviral Agents | 2 | 2005 | 811 | 0.080 |
Why?
|
| Ophthalmoplegia | 2 | 2017 | 52 | 0.070 |
Why?
|
| Eye Injuries | 2 | 2000 | 49 | 0.070 |
Why?
|
| Ultrasonography | 3 | 2012 | 974 | 0.070 |
Why?
|
| Atropine | 2 | 2004 | 29 | 0.070 |
Why?
|
| Age Factors | 3 | 2004 | 2844 | 0.070 |
Why?
|
| Ocular Motility Disorders | 2 | 2017 | 35 | 0.070 |
Why?
|
| Adenoviruses, Human | 2 | 2005 | 97 | 0.070 |
Why?
|
| Receptors, Thyrotropin | 1 | 2007 | 8 | 0.060 |
Why?
|
| Microscopy, Acoustic | 1 | 2007 | 15 | 0.060 |
Why?
|
| Aged | 10 | 2005 | 20939 | 0.060 |
Why?
|
| Middle Aged | 9 | 2005 | 28459 | 0.060 |
Why?
|
| Light | 1 | 2007 | 170 | 0.060 |
Why?
|
| Incidence | 4 | 2002 | 3349 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2007 | 494 | 0.060 |
Why?
|
| Neoplasm Seeding | 1 | 2005 | 9 | 0.060 |
Why?
|
| Thymidine Kinase | 1 | 2005 | 89 | 0.060 |
Why?
|
| Vitreous Hemorrhage | 1 | 2005 | 7 | 0.060 |
Why?
|
| Ganciclovir | 1 | 2005 | 102 | 0.060 |
Why?
|
| Microphthalmos | 2 | 2003 | 53 | 0.060 |
Why?
|
| Cyclopentolate | 2 | 2004 | 4 | 0.060 |
Why?
|
| Trifluridine | 1 | 2004 | 10 | 0.050 |
Why?
|
| Fungi | 2 | 2003 | 73 | 0.050 |
Why?
|
| Office Management | 1 | 2004 | 4 | 0.050 |
Why?
|
| Practice Management | 1 | 2004 | 5 | 0.050 |
Why?
|
| Acyclovir | 1 | 2004 | 47 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 34 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1324 | 0.050 |
Why?
|
| Vidarabine | 1 | 2004 | 91 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1311 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2020 | 1232 | 0.050 |
Why?
|
| Community Participation | 1 | 2004 | 43 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2004 | 76 | 0.050 |
Why?
|
| Head Movements | 1 | 2004 | 13 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2007 | 1016 | 0.050 |
Why?
|
| Corneal Stroma | 1 | 2004 | 75 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2003 | 2103 | 0.050 |
Why?
|
| Fundus Oculi | 3 | 1999 | 35 | 0.050 |
Why?
|
| Pyrimethamine | 1 | 2003 | 2 | 0.050 |
Why?
|
| Sulfadiazine | 1 | 2003 | 2 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2007 | 438 | 0.050 |
Why?
|
| Nystagmus, Pathologic | 1 | 2004 | 21 | 0.050 |
Why?
|
| DNA, Protozoan | 1 | 2003 | 33 | 0.050 |
Why?
|
| Triamcinolone Acetonide | 1 | 2003 | 20 | 0.050 |
Why?
|
| Toxoplasma | 1 | 2003 | 18 | 0.050 |
Why?
|
| Leucovorin | 1 | 2003 | 54 | 0.050 |
Why?
|
| Antiprotozoal Agents | 1 | 2003 | 42 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2017 | 5087 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 2935 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 1999 | 970 | 0.050 |
Why?
|
| Antibodies, Protozoan | 1 | 2003 | 99 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 3410 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 85 | 0.050 |
Why?
|
| Endophthalmitis | 1 | 2003 | 49 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2007 | 448 | 0.050 |
Why?
|
| Capsulorhexis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Membranes | 1 | 2002 | 15 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2003 | 86 | 0.050 |
Why?
|
| Tendons | 1 | 2002 | 32 | 0.050 |
Why?
|
| Texas | 2 | 2002 | 3631 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2003 | 81 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2003 | 79 | 0.050 |
Why?
|
| Birth Weight | 3 | 2017 | 343 | 0.050 |
Why?
|
| Mutation | 2 | 2017 | 6138 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2005 | 1234 | 0.050 |
Why?
|
| Vitrectomy | 1 | 2002 | 41 | 0.050 |
Why?
|
| Animals | 4 | 2007 | 33829 | 0.050 |
Why?
|
| Fungemia | 1 | 2002 | 21 | 0.040 |
Why?
|
| Vision Screening | 1 | 2001 | 7 | 0.040 |
Why?
|
| Color | 1 | 2001 | 30 | 0.040 |
Why?
|
| Facial Muscles | 1 | 2001 | 25 | 0.040 |
Why?
|
| Myasthenia Gravis | 1 | 2002 | 31 | 0.040 |
Why?
|
| Blinking | 1 | 2001 | 27 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2003 | 351 | 0.040 |
Why?
|
| Eye Infections, Fungal | 1 | 2002 | 68 | 0.040 |
Why?
|
| Syndrome | 3 | 1999 | 1160 | 0.040 |
Why?
|
| Blepharoptosis | 1 | 2002 | 67 | 0.040 |
Why?
|
| Blepharospasm | 1 | 2001 | 46 | 0.040 |
Why?
|
| Conjunctiva | 1 | 2003 | 197 | 0.040 |
Why?
|
| Craniofacial Dysostosis | 1 | 2000 | 25 | 0.040 |
Why?
|
| Candidiasis | 1 | 2002 | 131 | 0.040 |
Why?
|
| Self Concept | 1 | 2001 | 162 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2001 | 225 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2000 | 48 | 0.040 |
Why?
|
| Radiography | 1 | 2002 | 739 | 0.040 |
Why?
|
| Tic Disorders | 1 | 2001 | 84 | 0.040 |
Why?
|
| Dystonic Disorders | 1 | 2001 | 97 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 790 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2000 | 31 | 0.040 |
Why?
|
| Office Visits | 1 | 2000 | 78 | 0.040 |
Why?
|
| Social Behavior | 1 | 2001 | 216 | 0.040 |
Why?
|
| Prejudice | 1 | 2000 | 40 | 0.040 |
Why?
|
| Aging | 2 | 2004 | 1251 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 3864 | 0.040 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1999 | 25 | 0.040 |
Why?
|
| Orbit | 1 | 2000 | 81 | 0.040 |
Why?
|
| Employment | 1 | 2000 | 70 | 0.040 |
Why?
|
| Filtering Surgery | 1 | 1999 | 4 | 0.040 |
Why?
|
| Age of Onset | 2 | 1998 | 597 | 0.040 |
Why?
|
| Intraocular Pressure | 2 | 1999 | 133 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 1457 | 0.040 |
Why?
|
| Glaucoma Drainage Implants | 1 | 1999 | 10 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2000 | 48 | 0.040 |
Why?
|
| Cardiovascular Abnormalities | 1 | 1999 | 53 | 0.040 |
Why?
|
| Dogs | 1 | 2000 | 614 | 0.040 |
Why?
|
| Aniseikonia | 1 | 1999 | 1 | 0.040 |
Why?
|
| Epiretinal Membrane | 1 | 1999 | 6 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1999 | 227 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2019 | 80 | 0.040 |
Why?
|
| 2-Propanol | 1 | 1998 | 4 | 0.040 |
Why?
|
| Outpatients | 1 | 2000 | 264 | 0.040 |
Why?
|
| Optic Neuritis | 1 | 1999 | 35 | 0.040 |
Why?
|
| Disinfection | 1 | 1998 | 25 | 0.040 |
Why?
|
| Fetus | 1 | 2002 | 584 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2003 | 899 | 0.040 |
Why?
|
| Caregivers | 1 | 2004 | 573 | 0.040 |
Why?
|
| Head Injuries, Closed | 1 | 1998 | 45 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1998 | 77 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2002 | 855 | 0.030 |
Why?
|
| Trisomy | 1 | 1998 | 112 | 0.030 |
Why?
|
| Fixation, Ocular | 1 | 1997 | 15 | 0.030 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1998 | 69 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 1997 | 64 | 0.030 |
Why?
|
| Medical Illustration | 1 | 1997 | 17 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2000 | 214 | 0.030 |
Why?
|
| Stents | 1 | 2003 | 780 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 35 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1999 | 770 | 0.030 |
Why?
|
| Gene Duplication | 1 | 1998 | 361 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4647 | 0.030 |
Why?
|
| Malformations of Cortical Development | 1 | 2017 | 59 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 66 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 123 | 0.030 |
Why?
|
| Forecasting | 1 | 1997 | 358 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2001 | 1051 | 0.030 |
Why?
|
| Survival Rate | 1 | 1999 | 2144 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2014 | 169 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2201 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2005 | 6782 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 1677 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1498 | 0.020 |
Why?
|
| Neurons | 1 | 2003 | 1988 | 0.020 |
Why?
|
| Exome | 1 | 2017 | 1077 | 0.020 |
Why?
|
| Carboplatin | 1 | 2012 | 77 | 0.020 |
Why?
|
| Etoposide | 1 | 2012 | 110 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2001 | 4022 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 340 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2012 | 137 | 0.020 |
Why?
|
| Vincristine | 1 | 2012 | 191 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 284 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 788 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 3060 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2011 | 554 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3817 | 0.020 |
Why?
|
| Reoperation | 2 | 2000 | 841 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 18 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 37 | 0.010 |
Why?
|
| Health Services | 1 | 2005 | 69 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2011 | 1086 | 0.010 |
Why?
|
| Tropicamide | 1 | 2004 | 5 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2004 | 36 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 342 | 0.010 |
Why?
|
| Pupil | 1 | 2004 | 45 | 0.010 |
Why?
|
| United States | 1 | 2019 | 11814 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2004 | 80 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 2003 | 77 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 828 | 0.010 |
Why?
|
| Candida albicans | 1 | 2003 | 87 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 241 | 0.010 |
Why?
|
| Pyridostigmine Bromide | 1 | 2002 | 10 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 900 | 0.010 |
Why?
|
| Thymectomy | 1 | 2002 | 23 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 459 | 0.010 |
Why?
|
| Muscle Denervation | 1 | 2000 | 7 | 0.010 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 87 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2005 | 718 | 0.010 |
Why?
|
| Psychosocial Deprivation | 1 | 2000 | 6 | 0.010 |
Why?
|
| Eye Protective Devices | 1 | 2000 | 11 | 0.010 |
Why?
|
| Bed Rest | 1 | 2000 | 24 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2000 | 112 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 15 | 0.010 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1999 | 24 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 501 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1999 | 24 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 1267 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2000 | 184 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1999 | 238 | 0.010 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1998 | 37 | 0.010 |
Why?
|
| Herpesvirus 2, Human | 1 | 1998 | 14 | 0.010 |
Why?
|
| Sickle Cell Trait | 1 | 1998 | 10 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 1999 | 28 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1999 | 95 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1999 | 188 | 0.010 |
Why?
|
| Karyotyping | 1 | 1998 | 312 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 144 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2000 | 406 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1998 | 841 | 0.010 |
Why?
|